BlaauboerB.J., BoekelheideK., ClewellH.J., DaneshianM., DingemansM.M., GoldbergA.M., HeneweerM., JaworskaJ., KramerN.I., LeistM., SeibertH., TestaiE., VandebrielR.J., YagerJ.D. & ZurloJ. (2012). The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. ALTEX29, 411-425.
2.
HoeltingL., ScheinhardtB., BondarenkoO., SchildknechtS., KapitzaM., TanavdeV., TanB., LeeQ.Y., MeckingS., LeistM. & KadereitS. (2013). A 3-dimensional human embryonic stem cell (hESC)-derived model to detect developmental neurotoxicity of nanoparticles. Archives of Toxicology87, 721-733.
3.
KrugA.K., KoldeR., GasparJ.A., RempelE., BalmerN.V., MeganathanK., VojnitsK., BaquiéM., WaldmannT., Ensenat-WaserR., JagtapS., EvansR.M., JulienS., PetersonH., ZagouraD., KadereitS., GerhardD., SotiriadouI., HekeM., NatarajanK., HenryM., WinklerJ., MarchanR., StoppiniL., BosgraS., WesterhoutJ., VerweiM., ViloJ., KortenkampA., HeschelerJ., HothornL., BremerS., van ThrielC., KrauseK.H., HengstlerJ.G., RahnenführerJ., LeistM. & SachinidisA. (2013). Human embryonic stem cell-derived test systems for developmental neurotoxicity: A transcriptomics approach. Archives of Toxicology87, 123-143.
4.
LeistM., LidburyB.A., YangC., HaydenP.J., KelmJ.M., RingeissenS., DetroyerA., MeunierJ.R., RathmanJ.F., JacksonG.R.Jr, StolperG. & HasiwaN. (2012). Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. ALTEX29, 373-388.
5.
PaparellaM., DaneshianM., Hornek-GaustererR., KinzlM., MauritzI. & MühleggerS. (2013). Uncertainty of testing methods - What do we (want to) know?ALTEX30, 131-144.
DavisM., BoekelheideK., BoverhofD.R., EichenbaumG., HartungT., HolsappleM.P., JonesT.W., RichardA.M. & WatkinsP.B. (2013). The new revolution in toxicology: The good, the bad, and the ugly. Annals of the New York Academy of Sciences1278, 11-24.